In Brief: Telectronics
This article was originally published in The Gray Sheet
Telectronics: Suspends U.S. product shipments under consent decree with FDA, firm announces May 19. According to Telectronics, the decree sets "specific steps" the firm must take to assure FDA that it is in compliance with good manufacturing practices regs. The agreement does not affect products already implanted or already shipped, or products for export outside U.S. Telectronics President Jim Dennis stresses that the decree "concerns manufacturing procedures only" and that the agency "has not alleged that any of the products currently marketed are defective in any way." The decree is unrelated to Accufix Atrial J Lead, which was subject to a safety alert in December 1994 and which Telectronics no longer produces ("The Gray Sheet" Jan. 2, p. 12)...
You may also be interested in...
Aker BioMarine seeks supplement firms to use its EPA/DHA innovation bound by lysophosphatidylcholine to enable the fatty acids to pass through the blood-brain and blood-retinal barriers and boost of eye and brain health benefits. It will submit an NDI notificaion in the US during 2022.
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.